Skip to content

A two-way cohort study on the efficacy evaluation of new clinical classification of hepatolithiasis

A two-way cohort study on the efficacy evaluation of new clinical classification of hepatolithiasis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100054399
Enrollment
Unknown
Registered
2021-12-17
Start date
2022-01-01
Completion date
Unknown
Last updated
2022-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatolithiasis

Interventions

Case series:None

Sponsors

The Sixth People's Hospital Affiliated to Shanghai Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Male or female patients aged 18 to 80 years; 2. Those diagnosed with hepatolithiasis by B-ultrasound, CT or MRI; 3. Child-Pugh score of liver function A-B; 4. Patients who voluntarily signed the informed consent and were able to complete the follow-up plan.

Exclusion criteria

Exclusion criteria: 1. Are pregnant or breastfeeding; 2. Patients with malignant or serious heart, lung, kidney or other system diseases; 3. Child-Pugh score of liver function C; 4. Combined with other hepatobiliary and pancreatic diseases such as extrahepatic bile duct stones; 5. Secondary intrahepatic bile duct stones; 6. Those who have no legal capacity or insight.

Design outcomes

Primary

MeasureTime frame
residue rate of stones;

Secondary

MeasureTime frame
recurrence rate of stones;quality of life;

Countries

China

Contacts

Public ContactWang Jian

The Sixth People's Hospital Affiliated to Shanghai Jiaotong University

dr_wangjian@126.com+86 13818965695

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026